Regenxbio (RGNX) Shares Outstanding (2014 - 2026)

Regenxbio's Shares Outstanding (Entity) history runs 12 years deep, the most recent figure standing at $50.9 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Entity) rose 2.71% year-over-year to $50.9 million; the TTM figure through Dec 2025 stood at $50.9 million (up 2.71% YoY), while the FY2025 annual figure was $50.9 million, up 2.71% from the prior year.
• Shares Outstanding (Entity) for Q4 2025 stood at $50.9 million, up from $50.6 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $50.9 million in Q4 2025, with the low at $42944.0 in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $43.1 million (2021), against an average of $32.9 million.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) tumbled 99.9% in 2022, then jumped 113191.68% in 2024.
• Regenxbio's Shares Outstanding (Entity) stood at $42.8 million in 2021, then increased by 1.09% to $43.3 million in 2022, then rose by 1.73% to $44.0 million in 2023, then rose by 12.49% to $49.5 million in 2024, then grew by 2.71% to $50.9 million in 2025.
• Business Quant data shows RGNX's Shares Outstanding (Entity) at $50.9 million in Q4 2025, $50.6 million in Q3 2025, and $50.4 million in Q2 2025.